Recombinant EGFR (Matuzumab Biosimilar) anticorps
Research Grade
Reactivité: Humain
ELISA
Hôte: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits EGFR (Matuzumab Biosimilar)
- EGFR (Matuzumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Mammalian Cells
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp EGFR (Matuzumab Biosimilar) est non-conjugé
-
Application
- ELISA
- Fonction
- Matuzumab Biosimilar - Anti-EGFR mAb
- Attributs du produit
- Antibody Type: IgG1-nd
- Classe de qualité
- Research Grade
- Isotype
- IgG1
-
anti-EGFR (Matuzumab Biosimilar) (Extracellular Domain) antibody
Reactivité: Humain BR, FACS, WB Hôte: Human Monoclonal unconjugated Recombinant Antibody
anti-EGFR (Matuzumab Biosimilar) (Extracellular Domain) antibodyReactivité: Humain BR, FACS, WB Hôte: Lapin Chimeric unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Stock
- -80 °C
- Stockage commentaire
- store at -80°C
-
- Antigène
- EGFR (Matuzumab Biosimilar)
- Abstract
- EGFR (Matuzumab Biosimilar) Produits
- Classe de substances
- Biosimilar
- Sujet
-
EMD-72000,H425,h425
Matuzumab (formerly EMD 72000) is a humanized monoclonal antibody for the treatment of cancer. It binds to the epidermal growth factor receptor (EGFR) with high affinity. - Numéro CAS
- 339186-68-4
-
Vous êtes ici:
